NCT03505892View on ClinicalTrials.gov

A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

June 5, 2018

Primary Completion Date

October 25, 2021

Study Completion Date

October 25, 2021

Conditions
Ankylosing Spondylitis (AS)
Trial Locations (1)

970

Hualien Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation, Hualien City

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY